Flourish Research acquires Diablo Clinical Research to expand therapeutic coverage
Acquiring Company
Flourish Research
Acquired Company
Diablo Clinical Research
ApexWalnut CreekBiotechnologyHealth CareMedicalBiotechnologyHealth CareMedicalDescription
Flourish Research, a leading multi-site clinical trial organization, has announced the acquisition of Diablo Clinical Research. This strategic acquisition expands Flourish's geographic footprint and adds additional therapeutic coverage, enabling the combined expertise to provide best-in-class service and accurate, timely data to support new and improved therapies.
Quick answer
Flourish Research is acquiring Diablo Clinical Research, announced February 18, 2025. Flourish Research is based in Apex, North Carolina, United States.
- How much did Flourish Research pay for Diablo Clinical Research?
- The deal value was not disclosed.
- What does Flourish Research do?
- Flourish Research is a leading multi-site clinical trial organization focused primarily on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas.
- Where are Flourish Research and Diablo Clinical Research based?
- Flourish Research is based in Apex, North Carolina, United States. Diablo Clinical Research is based in Walnut Creek, California, United States.
- Who are the decision-makers at Flourish Research?
- Fundz holds 1 contact at Flourish Research. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Globus Medical completes acquisition of Nevro Corp. (April 3, 2025)
- Vivo Infusion completes acquisition of Neurology Institute of San Antonio and Vista Infusions to expand infusion services (January 9, 2025)
- Lupin acquires UK-based Renascience Pharma (April 3, 2025)
- START acquires Carolina Urologic Research Center (March 18, 2025)
- Gleamer acquires Pixyl and Caerus Medical (March 11, 2025)
- Concentra acquires Miami-Dade clinics from PHC and OMM (March 10, 2025)
Who to call at Flourish Research, and when
When Flourish Research changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Flourish Research raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Flourish Research, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Flourish Research. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Flourish Research makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Diablo Clinical Research?
Diablo Clinical Research was acquired by Flourish Research, based in Apex. The deal was reported on February 18, 2025. Flourish Research is a leading multi-site clinical trial organization focused primarily on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas. Flourish Research is privately held and operates in Biotechnology.
When did Flourish Research acquire Diablo Clinical Research?
Flourish Research's acquisition of Diablo Clinical Research was reported on February 18, 2025. Flourish Research, a leading multi-site clinical trial organization, has announced the acquisition of Diablo Clinical Research. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Diablo Clinical Research do?
Diablo Clinical Research is a distinguished multi-therapeutic clinical research facility performing phase I-IV clinical trials and medical device studies. It is privately held, operating in Biotechnology, and is based in Walnut Creek.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.